Tuberculosis vaccine (Aeras/Crucell)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTuberculosis vaccine (Aeras/Crucell)
Drug Alias Name结核病菌苗 - Aeras/Crucell结核疫苗 - Aeras/CrucellAERAS-402/Crucell Ad35
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTuberculosis, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAerasCrucell Holland Bv
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsTuberculosis, Pulmonary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A